National hospital infection surveillance on methicillin-resistant Staphylococcus aureus

Dermatology : International Journal for Clinical and Investigative Dermatology
Hiroyoshi Kobayashi

Abstract

National hospital infection surveillances on methicillin-resistant Staphylococcus aureus (MRSA) had been carried out in 1995 and 1996. Recently, in the UK and the USA, the prevalence of MRSA has increased and strict precautions against MRSA are recommended. In Japan, hospital infection rates of MRSA have appeared to be stable in recent years, but a reevaluation is required to confirm this assumption. In a nationwide surveillance, the incidences of MRSA hospital infections per 100 admissions remained stable at between 0.7 and 0.8 from 1999 to 2003, with a tendency towards a slight decline being observed. This study shows that the precautions against MRSA infection in Japan may prove to be an effective preventive measure.

References

Dec 1, 1995·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J M Boyce
Feb 15, 2002·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·D Lepelletier, H Richet
Mar 5, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Margaret IpA F Cheng

❮ Previous
Next ❯

Citations

Dec 7, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Carolina EspinozaLuis Ostrosky-Zeichner
Jul 11, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M J C A van TrijpA Ott

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
J A Otter, G L French
© 2021 Meta ULC. All rights reserved